Welcome to our dedicated page for Accelerant Holdings SEC filings (Ticker: ARX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Accelerant Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Accelerant Holdings's regulatory disclosures and financial reporting.
Accelerant Holdings (ARX) Form 4 filing: Co-founder & CEO Jeffrey L. Radke was granted 8,279,552 stock options on 23 Jul 2025 at an exercise price of $21 per Class A common share. The options expire on 23 Jul 2035.
Vesting schedule: 25 % vests on 23 Jul 2026; the remaining 75 % vests in 6.25 % quarterly tranches through 23 Jul 2029, subject to continuous service. Following the grant, Radke beneficially owns the full 8.28 M derivative securities directly.
Take-aways for investors: the award is sizable and represents future dilution if exercised, but it strengthens management-shareholder alignment and serves as a long-term retention incentive for the CEO.
On 07/23/2025, Co-Founder & Chief Underwriting Officer Francis James O’Neill received a stock option covering 882,611 Class A common shares of Accelerant Holdings (ARX) at an exercise price of $21, as disclosed in a Form 4 filed 07/25/2025.
Vesting terms tie the award to long-term service: 25% vests on 07/23/2026 and the remaining 75% vests in 6.25% quarterly installments through 07/23/2029. The award is coded “A,” indicating a grant with no cash payment or share sale. O’Neill now beneficially owns 882,611 derivative securities, all held directly.
The grant increases potential dilution if exercised but aligns executive compensation with future share-price performance by requiring four years of continued service before full vesting.
Accelerant Holdings (ARX) filed a Form 4 indicating that Co-Founder, Director and Head of Distribution Christopher Lee-Smith received a new stock-option grant on 23 Jul 2025. The option allows him to purchase 2,746,261 Class A common shares at an exercise price of $21 and was reported on 25 Jul 2025.
Vesting terms are service-based: 25 % vests on 23 Jul 2026 (one-year cliff) and the remaining 75 % vests in 6.25 % quarterly installments through 23 Jul 2029. The option expires on 23 Jul 2035. After the transaction, Lee-Smith beneficially owns 2,746,261 derivative securities; no non-derivative share movement was disclosed.
The award strengthens management alignment over a four-year horizon, yet represents potential future dilution of roughly 2.75 million shares should the options be exercised.
On 07/23/2025, Accelerant Holdings (ARX) filed a Form 4 disclosing an initial grant of 209,515 stock options to newly appointed director Wendy Liisa Harrington.
- Exercise price: $21 per Class A common share.
- Vesting: 25 % cliff on 07/23/2026, then 6.25 % quarterly through 07/23/2029 (full vesting in four years), contingent on continuous service.
- Expiration: 07/23/2035 (10-year term).
- Post-transaction beneficial ownership: 209,515 derivative securities; no non-derivative share changes were reported.
The filing reflects a routine equity-compensation award meant to align director incentives with shareholder value. While the award represents potential future dilution, it is immaterial relative to ARX’s presumed outstanding share base and involves no cash outlay by the company today. No earnings data or other material corporate events were disclosed in this filing.
FAQ
What is the current stock price of Accelerant Holdings (ARX)?
